| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,453 | 0,553 | 22:44 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 26.03. | Sequana Medical NV: NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES / ISSUANCE OF A NEW SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM | 368 | GlobeNewswire (Europe) | Ghent, Belgium, March 26, 2026 (GLOBE NEWSWIRE) -- PRESS RELEASE REGULATED INFORMATION - INSIDE INFORMATION26 March 2026, 8:00 pm CET
Ghent, Belgium, 26 March 2026 - Sequana Medical NV
(Euronext... ► Artikel lesen | |
| 05.03. | Sequana Medical NV: NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES ISSUANCE OF A NEW SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM | 469 | GlobeNewswire (Europe) | Ghent, Belgium, March 05, 2026 (GLOBE NEWSWIRE) -- PRESS RELEASEREGULATED INFORMATION - INSIDE INFORMATION5 March 2026, 7:00 am CET
Ghent, Belgium, 5 March 2026 - Sequana Medical NV
(Euronext... ► Artikel lesen | |
| 26.02. | Sequana Medical NV: Sequana Medical Reports Strong US Commercial Progress with Five Centers Completing alfapump System Implants Since Launch | 437 | GlobeNewswire (Europe) | Ghent, Belgium, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Leading US liver transplant center completes its first two implantationsMount Sinai Hospital and University of Pennsylvania also complete multiple implantations... ► Artikel lesen | |
| 02.02. | Sequana Medical NV: SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM | 343 | GlobeNewswire (Europe) | Ghent, Belgium, Feb. 02, 2026 (GLOBE NEWSWIRE) --
PRESS RELEASEREGULATED INFORMATION - INSIDE INFORMATION2 February 2026, 6:00 pm CET
Ghent, Belgium, 2 February 2026 - Sequana Medical NV
(Euronext... ► Artikel lesen | |
| 27.01. | Sequana Medical NV: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES | 385 | GlobeNewswire (Europe) | Ghent, Belgium, Jan. 27, 2026 (GLOBE NEWSWIRE) -- SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT
AND NEW NUMBER OF SHARES
PRESS RELEASEREGULATED INFORMATION
27 January 2026, 7:00 am... ► Artikel lesen | |
| 06.01. | Sequana Medical NV: Transparency Notification from Shareholders | 486 | GlobeNewswire (Europe) | Ghent, Belgium, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Transparency Notification from ShareholdersPRESS RELEASEREGULATED INFORMATION
6 January 2026, 6:00 pm CET
Ghent, Belgium - 6 January 2026 -... ► Artikel lesen | |
| SEQUANA MEDICAL Aktie jetzt für 0€ handeln | |||||
| 23.12.25 | Sequana Medical NV: Sequana Medical announces execution of letter of intent to amend terms of the Kreos Loan | 742 | GlobeNewswire (Europe) | Ghent, Belgium, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Sequana Medical announces execution of letter of intent to amend terms of the Kreos Loan
PRESS RELEASE REGULATED INFORMATION / INSIDE INFORMATION23... ► Artikel lesen | |
| 22.12.25 | Sequana Medical NV: NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES ISSUANCE OF A NEW SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM | 689 | GlobeNewswire (Europe) | Ghent, Belgium, Dec. 22, 2025 (GLOBE NEWSWIRE) -- NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
ISSUANCE OF A NEW SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT... ► Artikel lesen | |
| 18.12.25 | Sequana Medical NV: Sequana Medical Announces Granting of Key Additional U.S. Patent for DSR | 522 | GlobeNewswire (Europe) | Ghent, Belgium, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Builds upon existing granted DSR patents in US, Europe, Japan and ChinaStrengthens DSR patent protection based upon extensive clinical and pre-clinical... ► Artikel lesen | |
| 17.12.25 | Sequana Medical NV: Transparency Notification from Shareholders | 404 | GlobeNewswire (Europe) | Ghent, Belgium, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Transparency Notification from ShareholdersPRESS RELEASEREGULATED INFORMATION
17 December 2025, 6:00 pm CET
Ghent, Belgium - 17 December 2025... ► Artikel lesen | |
| 11.12.25 | Sequana Medical NV: Sequana Medical Announces U.S. Commercial alfapump Implantations at University of Pennsylvania | 581 | GlobeNewswire (Europe) | Ghent, Belgium, Dec. 11, 2025 (GLOBE NEWSWIRE) -- First implantation of two alfapump patients on the same dayContinuing strategy of working with Key Opinion Leaders at top tier centersStrong pipeline... ► Artikel lesen | |
| 05.12.25 | Sequana Medical NV: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES | 428 | GlobeNewswire (Europe) | Ghent, Belgium, Dec. 05, 2025 (GLOBE NEWSWIRE) --
PRESS RELEASEREGULATED INFORMATION5 December 2025, 6:00 pm CET
Ghent, Belgium, 5 December 2025 - Sequana Medical NV
(Euronext Brussels:... ► Artikel lesen | |
| 24.11.25 | Sequana Medical NV: Transparency Notification from Shareholders | 518 | GlobeNewswire (Europe) | Ghent, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Transparency Notification from Shareholders
Ghent, Belgium - 24 November 2025 - Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana
Medical")... ► Artikel lesen | |
| 24.11.25 | Sequana Medical NV: Sequana Medical Announces First U.S. Commercial alfapump Implantation at Mount Sinai Hospital in New York | 668 | GlobeNewswire (Europe) | Ghent, Belgium, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Milestone in bringing breakthrough treatment option to US patients with recurrent and refractory ascites due to liver cirrhosisFeedback from hepatology... ► Artikel lesen | |
| 20.11.25 | Sequana Medical NV: SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM | 395 | GlobeNewswire (Europe) | Ghent - Belgium, Nov. 20, 2025 (GLOBE NEWSWIRE) -- SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM
PRESS RELEASEREGULATED... ► Artikel lesen | |
| 14.11.25 | Sequana Medical NV: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES | 503 | GlobeNewswire (Europe) | Ghent Belgium, Nov. 14, 2025 (GLOBE NEWSWIRE) -- SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT
AND NEW NUMBER OF SHARES
PRESS RELEASEREGULATED INFORMATION14 November 2025, 6:00 pm CET
Ghent... ► Artikel lesen | |
| 16.10.25 | Sequana Medical NV: NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES ISSUANCE OF A NEW SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM | 492 | GlobeNewswire (Europe) | Ghent, Oct. 16, 2025 (GLOBE NEWSWIRE) -- NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
ISSUANCE OF A NEW SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM
Ghent... ► Artikel lesen | |
| 14.10.25 | Sequana Medical NV: Sequana Medical alfapump System Highlighted at SIR EDGE 2025 Conference | 507 | GlobeNewswire (Europe) | , Oct. 14, 2025 (GLOBE NEWSWIRE) -- Ghent, Belgium - 14 October 2025 - Sequana Medical NV (Euronext Brussels: SEQUA (the "Company" or "Sequana Medical"), a pioneer in the treatment of drug-resistant... ► Artikel lesen | |
| 13.10.25 | Sequana Medical NV: Transparency Notification from Shareholder | 459 | GlobeNewswire (Europe) | Transparency Notification from Shareholder
Ghent, Belgium - 13 October 2025 - Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana
Medical"), a pioneer in the treatment... ► Artikel lesen | |
| 10.10.25 | Sequana Medical NV: Transparency Notification from Shareholder | 539 | GlobeNewswire (Europe) | Transparency Notification from Shareholder
Ghent, Belgium - 10 October 2025 - Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana
Medical"), a pioneer in the treatment... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 44,500 | -0,56 % | EQS-News: Fresenius SE & Co. KGaA: FutureFresenius zahlt sich aus: S&P Global Ratings hebt Ausblick für Fresenius SE von stabil auf positiv an | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Rating
FutureFresenius zahlt sich aus: S&P Global Ratings hebt Ausblick für Fresenius SE von stabil auf positiv an
08.04.2026... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 37,340 | -1,43 % | GOLDMAN SACHS stuft Siemens Healthineers auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Siemens Healthineers von 52 auf 45 Euro gesenkt, aber die Einstufung auf "Neutral" belassen. Vor der Berichtssaison... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 25,520 | -0,39 % | GOLDMAN SACHS stuft CARL ZEISS MEDITEC AG auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Carl Zeiss Meditec von 36 auf 31 Euro gesenkt, aber die Einstufung auf "Neutral" belassen. Die Aktien der Jenaer... ► Artikel lesen | |
| ECKERT & ZIEGLER | 14,370 | -2,38 % | Eckert&Ziegler mit Rekordsignal: Was große Adressen noch vor Börsenschluss bereits wissen - So reagieren erfahrene Anleger jetzt | ||
| UNITEDHEALTH | 262,40 | +0,08 % | UnitedHealth: Positive News von der US-Regierung - Aktie mit Kurssprung | Die Aktie des Versicherers UnitedHealth zeigte sich am Montag im regulären Handel bereits stark. Sie gehörte mit einem Plus von 1,5 Prozent zu den fünf besten Werten im US-Leitindex Dow Jones Industrial.... ► Artikel lesen | |
| GERRESHEIMER | 17,000 | -3,30 % | Shortseller-Positionen aktuell: u.a. Brenntag, Gerresheimer, Hugo Boss, Lanxess, Südzucker, TeamViewer, Zalando | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| DRAEGERWERK | 93,80 | -1,88 % | Draegerwerk AG & Co. KGaA: Online-Präsentation für Investoren als Teil der German Select 7 Conference am 14.04.2026 | Vor diesem Hintergrund veranstaltet mwb research am 14.04.2026 um 14:00 CEST einen Online-Roundtable mit Thomas Fischler (Head of Treasury & Investor Relations). Nach einer Präsentation besteht die... ► Artikel lesen | |
| MEDTRONIC | 75,42 | -0,74 % | Future Market Insights: Global Weight Loss and Obesity Management Market | 12.8% CAGR Growth Trajectory | Asia Pacific, North America Lead | Novo Nordisk, Eli Lilly, Medtronic Drive Integrated Care Evolution | NEWARK, Del., April 9, 2026 /PRNewswire/ -- According to the latest analysis by Future Market Insights, the global weight loss and obesity management market is undergoing a transformative... ► Artikel lesen | |
| THERMO FISHER | 428,70 | -0,69 % | Thermo Fisher, Singapore's PRECISE Partner on Population-Scale Proteomics Biobank | ||
| STRATEC | 17,000 | -2,07 % | DEUTSCHE BANK RESEARCH stuft STRATEC BIOMEDICAL SYSTEMS AG auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat das Kursziel für Stratec von 26 auf 23 Euro gesenkt, aber die Einstufung auf "Hold" belassen. Analyst Jan Koch schrieb in seinem am Freitag... ► Artikel lesen | |
| ESSILORLUXOTTICA | 199,65 | -0,92 % | BARCLAYS stuft EssilorLuxottica auf 'Overweight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für EssilorLuxottica vor Zahlen zum ersten Quartal von 355 auf 320 Euro gesenkt, die Einstufung aber auf "Overweight"... ► Artikel lesen | |
| HIMS & HERS HEALTH | 16,780 | +0,84 % | GraniteShares YieldBOOST HIMS ETF declares $0.1161 dividend | ||
| ALCON | 66,00 | -0,51 % | Alcon Launches Clareon TruPlus, Enhanced Design Monofocal and Toric IOLs, at ASCRS 2026 | TruPlus is designed to increase depth of focus while maintaining the high-quality distance vision surgeons expect from a monofocal IOL1,2 TruPlus demonstrates higher distance image quality... ► Artikel lesen | |
| RESMED | 195,05 | -1,37 % | RESMED INC: 144 Report of proposed sale of securities | ||
| HEALWELL AI | 0,510 | -0,97 % | HEALWELL AI erzielt Rekordumsatz und schließt erstes Jahr mit positivem bereinigtem EBITDA ab, da die globale KI-Plattformstrategie greift | - Rekordumsatzwachstum - HEALWELL erzielte im Geschäftsjahr 2025 einen Rekordjahresumsatz aus
fortlaufenden Betrieben in Höhe von ca. 103,8 Millionen Dollar. Dies entspricht einem Anstieg... ► Artikel lesen |